Literature DB >> 5726151

Freeze-drying various strains of Shigella.

S Berman, P L Altieri, A Groffinger, J P Lowenthal, S B Formal.   

Abstract

Of six candidate strains of Shigella prepared in Brain Heart Infusion broth as freeze-dried vaccine, low survival rates were obtained with two of the most promising strains. Survival rates with these two strains were increased to acceptable levels when the organisms were suspended in a medium consisting of 8.2% sucrose, 0.01 M phosphate, 0.07% monosodium glutamate, and 2.5% human serum albumin. Alteration of the freezing temperature did not improve the recovery rates significantly.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5726151      PMCID: PMC547759          DOI: 10.1128/am.16.11.1779-1781.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  6 in total

1.  Preservation of living cells by freeze-drying.

Authors:  R I GREAVES
Journal:  Ann N Y Acad Sci       Date:  1960-04-13       Impact factor: 5.691

2.  Physical factors implicated in the death of microorganisms at subzero temperatures.

Authors:  P MAZUR
Journal:  Ann N Y Acad Sci       Date:  1960-04-13       Impact factor: 5.691

3.  The influence of certain salts, amino acids, sugars, and proteins on the stability of rickettsiae.

Authors:  M R BOVARNICK; J C MILLER; J C SNYDER
Journal:  J Bacteriol       Date:  1950-04       Impact factor: 3.490

4.  EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY.

Authors:  E H Labrec; H Schneider; T J Magnani; S B Formal
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

5.  Biological properties of freeze-dried attenuated shigella vaccines.

Authors:  S B Formal; E H LaBrec; T H Kent; H C May; J P Lowenthal; S Berman
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

6.  ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.

Authors:  S B FORMAL; E H LABREC; T H KENT; S FALKOW
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.